CCRH and Adamas University Partner to Enhance Homoeopathy Research

The Central Council for Research in Homoeopathy (CCRH) inked a Memorandum of Understanding (MoU) with Adamas University, Kolkata, with a vision to improve academic and research partnerships in homeopathy.

Encube Opens Advanced Life Sciences R&D Centre at Palava

At the Lodha Lifesciences Hub in Palava, Encube Ethicals has formally opened its premier research and development center. With an unparalleled combination of state-of-the-art research facilities and a vibrant, carefully designed ecosystem, this...

ICMR strengthens aviation medicine with new Centre for Space Psychology

The ICMR will soon establish a Centre for Advanced Research on Space Psychology through its Extramural Research Project. It will harness mental and physiological preparedness for...

Poly Medicure Secures EU MDR Validation for Diverse Medical Devices

Poly Medicure is one of the world’s largest manufacturers of medical devices and has recently received Medical Device Regulation (MDR) validation for 54 of its products across diverse specialties such as infusion therapy, surgery & wound care....

Glenmark Pharma launches Empagliflozin in India

Empagliflozin, a well-known SGLT2 inhibitor, has been introduced in India by Glenmark Pharmaceuticals Ltd. (Glenmark), a multinational pharmaceutical business that prioritizes research.

India Aims for Rs 17,000 Crore Investment in Pharma R&D by FY28

India expects almost ?17,000 crore for the pharmaceutical research and development (R&D) in the period up to FY28, focusing on...

Zydus to Acquire 85.6% Stake in France-Based Amplitude Surgical

Zydus Lifesciences Limited, a global innovation-driven life sciences company, began exclusive negotiations to acquire an 85.6 percent stake in Amplitude Surgical, whereby the deal is proposed by...

Healthcare, Pharma in India Secure USD 30 Billion in M&A, PE Transactions

Capitalizing on demographic factors, technological advancements, and increasing demand for quality and preventive care, the healthcare sector of...

Syngene Intl acquires its first U.S. biologics manufacturing facility

Syngene International acquired its first biologics manufacturing site in the United States at $36.5 million, a major expansion in the...

Govt invites funding proposals for Pharma MedTech sector

The Department of Pharmaceuticals has invited expression of interest from entities for the purpose of project funding under the Promotion...

© 2025 India Pharma Outlook. All Rights Reserved.